EMJ GOLD

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.

Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.